Sfoglia per RIVISTA
THE LANCET. HAEMATOLOGY
Collezione AOU Alessandria

  

Items : 8

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes. in The Lancet. Haematology / Lancet Haematol. 2024 Nov;11(11):e862-e872. doi: 10.1016/S2352-3026(24)00251-5. Epub 2024 Oct 9.

2024
AOU Alessandria

Komrokji RS; Lanino L; Ball S; Bewersdorf JP; Marchetti M; Maggioni G; Travaglino E; Al Ali NH; Fenaux P; Platzbecker U; Santini V; Diez-Campelo M; Singh A; Jain AG; Aguirre LE; Tinsley-Vance SM; Schwabkey ZI; Chan O; Xie Z; Brunner AM; Kuykendall AT; Bennett JM; Buckstein R; Bejar R; Carraway HE; DeZern AE; Griffiths EA; Halene S; Hasserjian RP; et alii...

Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2024 Jul;11(7):e499-e509. doi: 10.1016/S2352-3026(24)00143-1.

2024
AOU Alessandria
AOU Città della Salute di Torino

Della Starza I; Drandi D; Genuardi E; Ciabatti E; Bomben R; De Novi LA; Cavalli M; Guarini A; Grapulin L; Assanto GM; Annechini G; Tani M; Celli M; Mannina D; Mannarella C; Cencini E; Re F; Bigliardi S; Corradini P; Stelitano C; Tucci A; Perrone T; Gaidano G; Musuraca G; Bernuzzi P; Bolis SA; Zilioli VR; Rattotti S; Ferreri AJM; et alii...

Diagnosis and management of Evans syndrome in adults: first consensus recommendations. in The Lancet. Haematology / Lancet Haematol. 2024 Aug;11(8):e617-e628. doi: 10.1016/S2352-3026(24)00144-3. Epub 2024 Jul 2.

2024
AOU Alessandria
AOU Novara

Patriarca A; Raso S; Arguello M; Mingot ME; Napolitano M; González-López TJ; Murakhovskaya I; Glenthøj A; Giordano G; Frederiksen H; Cantoni S; Michel M; Marchetti M; Fattizzo B; Vianelli N; Barcellini W;

Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations. in The Lancet. Haematology / Lancet Haematol. 2022 Apr;9(4):e301-e311. doi: 10.1016/S2352-3026(22)00046-1.

2022
AOU Alessandria

Marchetti M; Vannucchi AM; Griesshammer M; Harrison C; Koschmieder S; Gisslinger H; Álvarez-Larrán A; De Stefano V; Guglielmelli P; Palandri F; Passamonti F; Barosi G; Silver RT; Hehlmann R; Kiladjian JJ; Barbui T;

The role of autologous haematopoietic stem-cell transplantation in mantle cell lymphoma. in The Lancet. Haematology / Lancet Haematol. 2021 Sep;8(9):e617-e619. doi: 10.1016/S2352-3026(21)00237-4.

2021
AOU Alessandria

Chiappella A; Ladetto M;

Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Jan;8(1):e34-e44. doi: 10.1016/S2352-3026(20)30358-6. Epub 2020 Dec 22.

2021
AOU Alessandria
AOU Città della Salute di Torino

Vitolo U; Martelli M; Stelitano C; Ciccone G; Narni F; Casaroli I; Stefani PM; Puccini B; Benedetti F; Ferreri AJM; Molinari AL; Ballerini F; Arcaini L; Gomes da Silva M; Chiappella A; Zilioli VR; Balzarotti M; Stefoni V; Pagani C; Re A; Di Rocco A; Zanni M; Cavallo F; Mian M; Tavarozzi R; Ferrero S; Evangelista A; Ladetto M; Cortelazzo S; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Pinto A; Galieni P; Rigacci L; Candoni A; Venditti A; Fava C; Federici AB; Marchesi F; Musto P; Gentile M; Bocchia M; Di Renzo N; Olivieri A; Ferrandina C; Selleri C; Ortu La Barbera E; Luppi M; Scattolin AM; et alii...

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. in The Lancet. Haematology / Lancet Haematol. 2020 Feb;7(2):e157-e167. doi: 10.1016/S2352-3026(19)30256-X.

2020
AOU Alessandria

Penack O; Marchetti M; Ruutu T; Aljurf M; Bacigalupo A; Bonifazi F; Ciceri F; Cornelissen J; Malladi R; Duarte RF; Giebel S; Greinix H; Holler E; Lawitschka A; Mielke S; Mohty M; Arat M; Nagler A; Passweg J; Schoemans H; Socié G; Solano C; Vrhovac R; Zeiser R; Kröger N; Basak GW;